Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis (Q43745028)

26 November 2017

title

Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis (English)

1 reference

26 November 2017

1 reference

8

E Magnus Ohman

1 reference

26 November 2017

5

Sidney C Smith

1 reference

26 November 2017

12

Deepak L Bhatt

1 reference

26 November 2017

3

Christopher P Cannon

1 reference

26 November 2017

4

Kim A Eagle

1 reference

26 November 2017

Dharam J Kumbhani

1

1 reference

26 November 2017

P Gabriel Steg

2

1 reference

26 November 2017

Kevin Crowley

6

1 reference

26 November 2017

Shinya Goto

7

1 reference

26 November 2017

George L Bakris

9

1 reference

26 November 2017

Todd S Perlstein

10

1 reference

26 November 2017

Scott Kinlay

11

1 reference

26 November 2017

REACH Registry Investigators

13

1 reference

26 November 2017

publication date

9 November 2012

1 reference

26 November 2017

published in

European Heart Journal

1 reference

26 November 2017

volume

34

1 reference

26 November 2017

issue

16

1 reference

26 November 2017

page(s)

1204-1214

1 reference

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Outcome beyond blood pressure control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Resistant hypertension: an overview of evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Prevalence of resistant hypertension in the United States, 2003-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Incidence and prognosis of resistant hypertension in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Blood pressure is insufficiently controlled in European patients with established coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

One-year cardiovascular event rates in outpatients with atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Renal function and target organ damage in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

New therapeutic approaches to resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS368

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHS368

1 reference

26 November 2017

1 reference